Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
Ruth E. Uhlmann, Christine Rother, Jay Rasmussen, et al.
Nature Neuroscience (2020) Vol. 23, Iss. 12, pp. 1580-1588
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
Nicholas J. Ashton, Tharick A. Pascoal, Thomas K. Karikari, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 5, pp. 709-724
Open Access | Times Cited: 467
Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy
Sandro Dá Mesquita, Zachary Papadopoulos, Taitea Dykstra, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 255-260
Open Access | Times Cited: 266
The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline
Per Borghammer
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 455-474
Open Access | Times Cited: 168
Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
Martin Tolar, John A. Hey, Aidan Power, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6355-6355
Open Access | Times Cited: 139
Mouse Models of Alzheimer’s Disease
Miyabishara Yokoyama, Honoka Kobayashi, Lisa Tatsumi, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 133
Alzheimer's disease: From immunotherapy to immunoprevention
Mathias Jucker, Lary C. Walker
Cell (2023) Vol. 186, Iss. 20, pp. 4260-4270
Open Access | Times Cited: 125
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
Estrella Morenas‐Rodríguez, Yan Li, Brigitte Nuscher, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 4, pp. 329-341
Open Access | Times Cited: 120
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
Nicholas J. Ashton, Andréa Lessa Benedet, Tharick A. Pascoal, et al.
EBioMedicine (2022) Vol. 76, pp. 103836-103836
Open Access | Times Cited: 119
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
Christian Haass, Dennis J. Selkoe
PLoS Biology (2022) Vol. 20, Iss. 7, pp. e3001694-e3001694
Open Access | Times Cited: 105
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Anne‐Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3895-3895
Open Access | Times Cited: 52
β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice
Yini Zhao, Qiuyang Zheng, Yujuan Hong, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 7, pp. 1170-1184
Closed Access | Times Cited: 42
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Sudipta Senapati, Kuldeep Tripathi, Khadeja Awad, et al.
Small (2024) Vol. 20, Iss. 31
Open Access | Times Cited: 17
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease
Eric McDade, Iryna Voytyuk, Paul Aisen, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 11, pp. 703-714
Closed Access | Times Cited: 103
Combating deleterious phase transitions in neurodegenerative disease
April L. Darling, James Shorter
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1868, Iss. 5, pp. 118984-118984
Open Access | Times Cited: 80
Staging of Alzheimer’s disease: past, present, and future perspectives
Joseph Therriault, Eduardo R. Zimmer, Andréa Lessa Benedet, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 9, pp. 726-741
Open Access | Times Cited: 65
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Jessica Wagner, Karoline Degenhardt, Marleen Veit, et al.
Nature (2022) Vol. 612, Iss. 7938, pp. 123-131
Open Access | Times Cited: 62
Early diagnosis and treatment of Alzheimer’s disease by targeting toxic soluble Aβ oligomers
Maram Habashi, Suresh Vutla, Kuldeep Tripathi, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 49
Open Access | Times Cited: 51
Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 11, pp. 1048-1060
Open Access | Times Cited: 36
Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils
Martin Muschol, Wolfgang Hoyer
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 28
Protein nanoparticles as drug delivery systems for cancer theranostics
Yue Hua, Zibo Qin, Lin Gao, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 429-444
Closed Access | Times Cited: 10
The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention
Martin Tolar, John A. Hey, Aidan Power, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2727-2727
Open Access | Times Cited: 9
Aβ Plaques.
Lary C. Walker
DOAJ (DOAJ: Directory of Open Access Journals) (2020) Vol. 1
Closed Access | Times Cited: 59
Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
Serena Silvestro, Andrea Valeri, Emanuela Mazzon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2011-2011
Open Access | Times Cited: 29
Microbiota-derived lysophosphatidylcholine alleviates Alzheimer’s disease pathology via suppressing ferroptosis
Xu Zha, Xicheng Liu, Mengping Wei, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 6
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
Han Koh, SangJoon Lee, Hyo Lee, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13136-13136
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top